Want to see HK:8307 full AI Analyst Report?
8307 Stock Chart & Stats
HK$0.17
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.17
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.22
Previous CloseN/A
Volume16.00K
Average Volume (3M)8.13K
Market Cap
HK$44.43M
Enterprise ValueHK$42.34M
Total Cash (Recent Filing)HK$29.46M
Total Debt (Recent Filing)HK$17.57M
Price to Earnings (P/E)1120.0
Beta0.37
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.69%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding396,736,000
10 Day Avg. Volume24,400
30 Day Avg. Volume8,133
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)11.39
Price to Sales (P/S)1.24
P/FCF Ratio13.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Positive Cash GenerationConsistently positive operating and free cash flow indicates the business has generated cash internally across the reported period. Although FY2026 free cash flow declined materially, ongoing cash generation provides liquidity support and can help fund operations without relying entirely on external financing.
Sustained EBITDA MarginsPositive mid-teens EBITDA margins across four reported years show that the underlying operating model has retained earnings capacity despite revenue volatility. This durability provides a foundation for recovery if sales stabilize, while supporting continued operations and potential cash generation.
Return To ProfitabilityThe return to positive net income in FY2026 marks an improvement from losses recorded in FY2023 through FY2025. While profitability remains thin, restored earnings combined with positive free cash flow strengthens near-term financial resilience and offers a base for further operating improvement.
Bears Say
Elevated Balance-sheet LeverageLeverage remains materially above the company’s historical levels, increasing balance-sheet risk even after total debt declined from FY2025. High debt relative to equity can reduce financial flexibility, constrain investment choices, and make weaker operating performance more difficult to absorb.
Weak And Volatile RevenueRecent revenue contraction and the broader pattern of volatility weaken confidence in near-term growth durability. A smaller sales base can limit operating leverage, reduce the ability to cover fixed costs, and make the company’s return to sustained profitability more dependent on uncertain recovery.
Gross-margin DeteriorationThe sharp gross-margin decline signals weaker earnings quality and reduced profitability protection, whether driven by cost pressure or a mix shift noted in the financial analysis. Combined with only a roughly 2% net margin, it leaves limited room for further operating setbacks.
8307 FAQ
What was Medicskin Holdings Ltd.’s price range in the past 12 months?
Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.22 in the past 12 months.
What is Medicskin Holdings Ltd.’s market cap?
Medicskin Holdings Ltd.’s market cap is HK$44.43M.
When is Medicskin Holdings Ltd.’s upcoming earnings report date?
Medicskin Holdings Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 56 days.
How were Medicskin Holdings Ltd.’s earnings last quarter?
Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter.
Is Medicskin Holdings Ltd. overvalued?
According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued.
Does Medicskin Holdings Ltd. pay dividends?
Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of 7.69%. See more information on Medicskin Holdings Ltd. dividends here
What is Medicskin Holdings Ltd.’s EPS estimate?
Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicskin Holdings Ltd. have?
Medicskin Holdings Ltd. has 396,736,000 shares outstanding.
What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?
Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report. Following the earnings report the stock price went up 22.549%.
Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8307
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medicskin Holdings Ltd.
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Raily Aesthetic Medicine International Holdings Limited
―
Beauty Farm Medical & Health Industry, Inc.
―
Arrail Group Ltd.
―
Saint Bella Inc.
―